Clinical Trials Browser

Phase 1 × Not yet recruiting × spartalizumab × Clear all

NCT07318636 2026-01-06

NK-cell Therapy Combined With PD-1 Antibody and Platinum-Based Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC

Phase 1 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06364787 2024-04-15

Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial for First-line Treatment of Hepatocellular Carcinoma

Phase 1 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular